IntegraGen SA
ALINT.PA·Paris·Healthcare
0.1040+0.0340 (+48.57%)today
At close: Oct 23, 5:35 PM CEST · May be delayed up to 15 min · EUR
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Previous close0.0700
Open0.0790
Day range0.07900.1160
52-week range0.01300.3610
Off day high−10.34%
Off 52-week high−71.19%
Volume199.71K
Avg. volume (3M)68.96K
Market cap688.55K
EPS (TTM)-0.0200
Forward P/E—
P/E ratio (TTM)—
Dividend yield—
Beta (5Y)0.52
Shares outstanding6.61M
Short interest—
Earnings dateApr 29, 2025
Analyst target—
Profit margin−53.06%
Against its peers
Compare in full ›| ALINT.PA | VRAX | AIM | IMNN | CDIO | CSBR | |
|---|---|---|---|---|---|---|
| Market cap | 688.55K | 1.64M | 6.24M | 6.93M | 5.00M | 65.70M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | — | -0.2 | -0.4 | -0.7 | -6.8 | 47.2 |
| Price/book | -0.8 | 0.1 | 0.6 | 3.0 | 0.7 | 16.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −55.56% | −91.56% | −94.02% | −74.23% | −57.90% | −30.91% |
| Today | +48.57% | −1.21% | −2.92% | −1.20% | −0.88% | −0.84% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ALINT.PA news ›ABL Texcell Acquires IntegraGen
France’s ABL Texcell Acquires Precision Oncology Developer IntegraGen GenomeWeb Franceâs ABL Texcell Acquires Precision Oncology Developer IntegraGen
From articles in the 4Search news index.
In the news
1mentions in 30 days
1with it in the headline
Mixedsentiment
Mentioned with
Themes
Most coverage from
-
genomeweb.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.